Co-processing of Atorvastatin and Ezetimibe for Enhanced Dissolution Rate: In Vitro and In Vivo Correlation.

Arafa, Mona F; Alshaikh, Rasha A; Abdelquader, Magdy M; El Maghraby, Gamal M

Arafa, Mona F; Alshaikh, Rasha A; Abdelquader, Magdy M; El Maghraby, Gamal M.

Afiliação

Arafa MF; Department of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt. drmona_arafa@yahoo.com.
Alshaikh RA; Department of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt.
Abdelquader MM; School of Pharmacy, University College of Cork, Cork, Ireland.
El Maghraby GM; Department of Pharmaceutical Technology, College of Pharmacy, University of Tanta, Tanta, Egypt.

AAPS PharmSciTech ; 22(2): 59, 2021 Jan 31.

Article em En | MEDLINE | ID: mdl-33517486

Assuntos

Anticolesterolemiantes/administração & dosagem; Atorvastatina/administração & dosagem; Ezetimiba/administração & dosagem; Animais; Anticolesterolemiantes/farmacologia; Atorvastatina/química; Atorvastatina/farmacologia; Combinação de Medicamentos; Liberação Controlada de Fármacos; Ezetimiba/química; Ezetimiba/farmacologia; Masculino; Camundongos

Palavras-chave

antihyperlipidemic; atorvastatin; eutectic mixture; ezetimibe; fixed dose combination

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Ezetimiba / Atorvastatina / Anticolesterolemiantes Limite: Animals Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google